[Form 4] The Vita Coco Company, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Kenneth Sadowsky, a director of The Vita Coco Company, Inc. (COCO), sold 3,900 shares of common stock under a Rule 10b5-1 trading plan on 08/20/2025 at a weighted average price of $35.448, with transaction prices ranging from $34.91 to $35.78. After the sale he beneficially owned 627,766 shares directly. The filing also reports a fully vested non-qualified stock option with a $10.178 exercise price covering 27,300 shares, exercisable through 01/02/2030. The Form 4 was signed by Alison Klein as attorney-in-fact on 08/22/2025. The filing indicates the sale was effected pursuant to a pre-established trading plan and discloses the weighted average and price range for the multiple trades executed.

Positive

• Sale executed under a Rule 10b5-1 trading plan, indicating the transaction was pre-arranged for compliance with insider trading rules
• Detailed price disclosure: weighted average price $35.448 and execution range $34.91 to $35.78 are provided
• Significant retained direct ownership after the sale: 627,766 shares remain beneficially owned
• Vested equity compensation disclosed: a fully vested non-qualified option for 27,300 shares at a $10.178 exercise price

Negative

• Reported disposition of shares: 3,900 shares were sold, reducing the reporting person’s holdings
• Potential dilution if the disclosed options are exercised: 27,300 underlying shares could increase outstanding shares

Insights

Securities Analyst

TL;DR: Director sold a small block under a 10b5-1 plan while retaining substantial holdings and holding vested options.

The reported sale of 3,900 shares appears to be routine and executed under a Rule 10b5-1 plan, which offers procedural protections and signals the trades were pre-planned rather than opportunistic. Post-transaction direct beneficial ownership of 627,766 shares shows continued alignment with shareholders. The disclosure of a fully vested non-qualified option exercisable until 01/02/2030 provides potential future dilution if exercised but also indicates long-term compensation remains in equity form. No other material events, such as large dispositions or abrupt departures, are reported.

Corporate Governance Expert

TL;DR: Filing documents compliance with Section 16 and use of a 10b5-1 plan; transaction size is limited relative to disclosed holdings.

The Form 4 properly documents the director relationship, transaction date, and use of a 10b5-1 trading plan, which supports compliance with insider trading rules. The filing also transparently provides the weighted average sale price and the range of execution prices and includes a signature by an attorney-in-fact. The existence of vested options is disclosed, with clear exercise price and amount, helping stakeholders assess potential future equity issuance. No governance concerns such as unexplained accelerated sales or amendments are evident from the content provided.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sadowsky Kenneth

(Last) (First) (Middle)

250 PARK AVE SOUTH

SEVENTH FLOOR

(Street)

NEW YORK NY 10003

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/20/2025		S(1)		3,900	D	$35.448(2)	627,766	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$10.178							(3)	01/02/2030	Common Stock	27,300		27,300	D

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.91 to $35.78, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. The stock option is fully vested and currently exercisable.

	By: Alison Klein, Attorney-in-Fact For: Kenneth Sadowsky	08/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Kenneth Sadowsky disclose in the Form 4 for COCO?

The filing reports the sale of 3,900 common shares on 08/20/2025 under a Rule 10b5-1 plan at a weighted average price of $35.448 and retained 627,766 shares beneficially.

Were the sales by Kenneth Sadowsky part of a pre-established plan?

Yes. The Form 4 states the sales were effected pursuant to a Rule 10b5-1 trading plan.

Does Kenneth Sadowsky hold any stock options disclosed in the filing?

Yes. The filing discloses a fully vested non-qualified stock option with a $10.178 exercise price covering 27,300 shares, exercisable through 01/02/2030.

What prices were shares sold at according to the Form 4?

The filing reports a weighted average of $35.448 and states individual sale prices ranged from $34.91 to $35.78.

Who signed the Form 4 and when was it signed?

The Form 4 was signed by Alison Klein as attorney-in-fact for Kenneth Sadowsky on 08/22/2025.